FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+29.05%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$198M
AUM Growth
+$198M
(+4.3%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-22.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
10x Genomics
TXG
|
$45.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $181M | 91.29% | 1,000,000 -250,000 | -20% | -$45.3M |
|
2
Novavax
NVAX
$1.21B
| $12.1M | 6.11% | 66,810 | – | – |
|
|
XLRN
3
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.59M | 1.31% | 19,100 | – | – |
|
|
EPZM
4
DELISTED
Epizyme, Inc
EPZM
| $2.56M | 1.29% | 293,759 | – | – |
|